Topical Antineoplastic Alkylating Agents

Topical antineoplastic alkylating agents are locally administered anticancer medications designed to deliver cytotoxic therapy directly to cutaneous lesions while minimizing systemic absorption Therapeutically, this specialized drug class serves as skin-directed chemotherapy primarily indicated for the treatment of early-stage cutaneous T-cell lymphoma, specifically mycosis fungoides

As bifunctional or polyfunctional alkylating agents—most notably mechlorethamine (nitrogen mustard)—they exert their therapeutic effect by transferring alkyl groups to cellular DNA, causing interstrand cross-linking, inhibition of DNA replication and transcription, and subsequent apoptotic cell death in rapidly proliferating malignant cells

As bifunctional or polyfunctional alkylating agents—most notably mechlorethamine (nitrogen mustard)—they exert their therapeutic effect by transferring alkyl groups to cellular DNA, causing interstrand cross-linking, inhibition of DNA replication and transcription, and subsequent apoptotic cell death in rapidly proliferating malignant cells

Therapeutically, this specialized drug class serves as skin-directed chemotherapy primarily indicated for the treatment of early-stage cutaneous T-cell lymphoma, specifically mycosis fungoides